About CETSA®
One unique proven assay, multiple applications
CETSA is our well recognized, best-in-class core technology used to assess cellular protein-ligand binding. Unlike other target engagement methods, CETSA allows assessment and quantification in cellular environments under actual physiological conditions – without the need to modify the compound or protein.
CETSA can be applied in every step of the drug discovery value chain, and no matter which cellular matrix you choose, we generate biologically relevant data that helps you prioritize and confirm drug candidates faster.
Intellectual Property
Pelago Bioscience was founded to provide and develop the patented Cellular Thermal Shift Assay (CETSA) in 2013. The CETSA method is patented in most regions worldwide (IP documentation).
A shared goal
As your extended team, we have a shared goal, which gives us a natural commitment to your project, by heart. We lead, guide and advise to give your project progress.